Sofwave Medical Ltd

XTAE:SOFW (Israel)  
₪ 17.05 (-4.54%) Sep 19
At Loss
P/B:
6.26
Market Cap:
₪ 585.26M ($ 154.75M)
Enterprise V:
₪ 507.20M ($ 134.11M)
Volume:
11.24K
Avg Vol (2M):
10.94K
Trade In:
Volume:
11.24K
At Loss
Avg Vol (2M):
10.94K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Sofwave Medical Ltd ( XTAE:SOFW ) from 2021 to Sep 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Sofwave Medical stock (XTAE:SOFW) PE ratio as of Sep 22 2024 is 0. More Details

Sofwave Medical Ltd (XTAE:SOFW) PE Ratio (TTM) Chart

To

Sofwave Medical Ltd (XTAE:SOFW) PE Ratio (TTM) Historical Data

Total 801
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 9
Sofwave Medical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-22 At Loss 2024-07-18 At Loss
2024-09-19 At Loss 2024-07-17 At Loss
2024-09-18 At Loss 2024-07-16 At Loss
2024-09-17 At Loss 2024-07-15 At Loss
2024-09-16 At Loss 2024-07-14 At Loss
2024-09-15 At Loss 2024-07-11 At Loss
2024-09-12 At Loss 2024-07-10 At Loss
2024-09-11 At Loss 2024-07-09 At Loss
2024-09-10 At Loss 2024-07-08 At Loss
2024-09-09 At Loss 2024-07-07 At Loss
2024-09-08 At Loss 2024-07-04 At Loss
2024-09-05 At Loss 2024-07-03 At Loss
2024-09-04 At Loss 2024-07-02 At Loss
2024-09-03 At Loss 2024-07-01 At Loss
2024-09-02 At Loss 2024-06-30 At Loss
2024-09-01 At Loss 2024-06-27 At Loss
2024-08-29 At Loss 2024-06-26 At Loss
2024-08-28 At Loss 2024-06-25 At Loss
2024-08-27 At Loss 2024-06-24 At Loss
2024-08-26 At Loss 2024-06-23 At Loss
2024-08-25 At Loss 2024-06-20 At Loss
2024-08-22 At Loss 2024-06-19 At Loss
2024-08-21 At Loss 2024-06-18 At Loss
2024-08-20 At Loss 2024-06-17 At Loss
2024-08-19 At Loss 2024-06-16 At Loss
2024-08-18 At Loss 2024-06-13 At Loss
2024-08-15 At Loss 2024-06-10 At Loss
2024-08-14 At Loss 2024-06-09 At Loss
2024-08-12 At Loss 2024-06-06 At Loss
2024-08-11 At Loss 2024-06-05 At Loss
2024-08-08 At Loss 2024-06-04 At Loss
2024-08-07 At Loss 2024-06-03 At Loss
2024-08-06 At Loss 2024-06-02 At Loss
2024-08-05 At Loss 2024-05-30 At Loss
2024-08-04 At Loss 2024-05-29 At Loss
2024-08-01 At Loss 2024-05-28 At Loss
2024-07-31 At Loss 2024-05-27 At Loss
2024-07-30 At Loss 2024-05-26 At Loss
2024-07-29 At Loss 2024-05-23 At Loss
2024-07-28 At Loss 2024-05-22 At Loss
2024-07-25 At Loss 2024-05-21 At Loss
2024-07-24 At Loss 2024-05-20 At Loss
2024-07-23 At Loss 2024-05-19 At Loss
2024-07-22 At Loss 2024-05-16 At Loss
2024-07-21 At Loss 2024-05-15 At Loss

Sofwave Medical Ltd (XTAE:SOFW) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Sofwave Medical Ltd is engaged in the development, marketing, and production of non-invasive technology for skin rejuvenation and firming treatment.